Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients

A. Buck; V.M. Prade; T. Kunzke; A. Feuchtinger; D. Kroll; M. Feith; B. Dislich; B. Balluff; R. Langer; A. Walch

doi:10.1002/path.5828

Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients

A. Buck, V.M. Prade, T. Kunzke, A. Feuchtinger, D. Kroll, M. Feith, B. Dislich, B. Balluff, R. Langer^*, A. Walch^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	202-213
Number of pages	12
Journal	Journal of Pathology
Volume	256
Issue number	2
Early online date	4 Dec 2021
DOIs	https://doi.org/10.1002/path.5828
Publication status	Published - Feb 2022

Keywords

esophageal cancer
spatial metabolomics
imaging mass spectrometry
patient stratification
metabolic response evaluation
tumor regression grading
artificial intelligence
machine learning
PREOPERATIVE CHEMORADIOTHERAPY
PERIOPERATIVE CHEMOTHERAPY
NODAL STATUS
CANCER
CARCINOMA
POLYMORPHISM
MULTICENTER
EXPRESSION
PET

Access to Document

10.1002/path.5828Licence: CC BY

Cite this

@article{280d87c435fd40d0b10d022f27a42928,

title = "Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients",

keywords = "esophageal cancer, spatial metabolomics, imaging mass spectrometry, patient stratification, metabolic response evaluation, tumor regression grading, artificial intelligence, machine learning, PREOPERATIVE CHEMORADIOTHERAPY, PERIOPERATIVE CHEMOTHERAPY, NODAL STATUS, CANCER, CARCINOMA, POLYMORPHISM, MULTICENTER, EXPRESSION, PET",

author = "A. Buck and V.M. Prade and T. Kunzke and A. Feuchtinger and D. Kroll and M. Feith and B. Dislich and B. Balluff and R. Langer and A. Walch",

year = "2022",

month = feb,

doi = "10.1002/path.5828",

language = "English",

volume = "256",

pages = "202--213",

journal = "Journal of Pathology",

issn = "0022-3417",

publisher = "Wiley",

number = "2",

}

Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients. / Buck, A.; Prade, V.M.; Kunzke, T.; Feuchtinger, A.; Kroll, D.; Feith, M.; Dislich, B.; Balluff, B.; Langer, R.; Walch, A.

In: Journal of Pathology, Vol. 256, No. 2, 02.2022, p. 202-213.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients

AU - Buck, A.

AU - Prade, V.M.

AU - Kunzke, T.

AU - Feuchtinger, A.

AU - Kroll, D.

AU - Feith, M.

AU - Dislich, B.

AU - Balluff, B.

AU - Langer, R.

AU - Walch, A.

PY - 2022/2

Y1 - 2022/2

KW - esophageal cancer

KW - spatial metabolomics

KW - imaging mass spectrometry

KW - patient stratification

KW - metabolic response evaluation

KW - tumor regression grading

KW - artificial intelligence

KW - machine learning

KW - PREOPERATIVE CHEMORADIOTHERAPY

KW - PERIOPERATIVE CHEMOTHERAPY

KW - NODAL STATUS

KW - CANCER

KW - CARCINOMA

KW - POLYMORPHISM

KW - MULTICENTER

KW - EXPRESSION

KW - PET

U2 - 10.1002/path.5828

DO - 10.1002/path.5828

M3 - Article

C2 - 34719782

VL - 256

SP - 202

EP - 213

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -